US 7790713
Inhibitors of interleukin-1β converting enzyme
granted A61KA61K38/00A61P
Quick answer
US patent 7790713 (Inhibitors of interleukin-1β converting enzyme) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/04